Unknown

Dataset Information

0

TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.


ABSTRACT: The telomeric protein TRF2 is overexpressed in several human malignancies and contributes to tumorigenesis even though the molecular mechanism is not completely understood. By using a high-throughput approach based on the multiplexed Luminex X-MAP technology, we demonstrated that TRF2 dramatically affects VEGF-A level in the secretome of cancer cells, promoting endothelial cell-differentiation and angiogenesis. The pro-angiogenic effect of TRF2 is independent from its role in telomere capping. Instead, TRF2 binding to a distal regulatory element promotes the expression of SULF2, an endoglucosamine-6-sulfatase that impairs the VEGF-A association to the plasma membrane by inducing post-synthetic modification of heparan sulfate proteoglycans (HSPGs). Finally, we addressed the clinical relevance of our findings showing that TRF2/SULF2 expression is a worse prognostic biomarker in colorectal cancer (CRC) patients.

SUBMITTER: Zizza P 

PROVIDER: S-EPMC6468246 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5302982 | biostudies-literature
| S-EPMC2751566 | biostudies-literature
| S-EPMC3672077 | biostudies-literature
| S-EPMC9580248 | biostudies-literature
| S-EPMC8063955 | biostudies-literature
| S-EPMC5477571 | biostudies-literature
| S-EPMC9402878 | biostudies-literature
| S-EPMC4266619 | biostudies-literature
| S-EPMC4394202 | biostudies-literature
| S-EPMC3178550 | biostudies-literature